Morgan Stanley’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $586M | Buy |
|
|||||
|
2025
Q1 | $533M | Buy |
|
|||||
|
2024
Q4 | $528M | Buy |
|
|||||
|
2024
Q3 | $378M | Sell |
|
|||||
|
2024
Q2 | $605M | Buy |
|
|||||
|
2024
Q1 | $590M | Sell |
|
|||||
|
2023
Q4 | $931M | Buy |
|
|||||
|
2023
Q3 | $491M | Sell |
|
|||||
|
2023
Q2 | $725M | Buy |
|
|||||
|
2023
Q1 | $566M | Sell |
|
|||||
|
2022
Q4 | $536M | Buy |
|
|||||
|
2022
Q3 | $523M | Buy |
|
|||||
|
2022
Q2 | $595M | Buy |
|
|||||
|
2022
Q1 | $381M | Sell |
|
|||||
|
2021
Q4 | $479M | Buy |
|
|||||
|
2021
Q3 | $384M | Buy |
|
|||||
|
2021
Q2 | $332M | Buy |
|
|||||
|
2021
Q1 | $254M | Buy |
|
|||||
|
2020
Q4 | $257M | Buy |
|
|||||
|
2020
Q3 | $210M | Buy |
|
|||||
|
2020
Q2 | $170M | Buy |
|
|||||
|
2020
Q1 | $150M | Sell |
|
|||||
|
2019
Q4 | $237M | Buy |
|
|||||
|
2019
Q3 | $166M | Sell |
|
|||||
|
2019
Q2 | $185M | Buy |
|
|||||
|
2019
Q1 | $165M | Sell |
|
|||||
|
2018
Q4 | $164M | Buy |
|
|||||
|
2018
Q3 | $182M | Sell |
|
|||||
|
2018
Q2 | $194M | Buy |
|
|||||
|
2018
Q1 | $134M | Sell |
|
|||||
|
2017
Q4 | $146M | Buy |
|
|||||
|
2017
Q3 | $126M | Buy |
|
|||||
|
2017
Q2 | $130M | Sell |
|
|||||
|
2017
Q1 | $140M | Buy |
|
|||||
|
2016
Q4 | $108M | Sell |
|
|||||
|
2016
Q3 | $218M | Sell |
|
|||||
|
2016
Q2 | $210M | Buy |
|
|||||
|
2016
Q1 | $150M | Buy |
|
|||||
|
2015
Q4 | $117M | Buy |
|
|||||
|
2015
Q3 | $73.9M | Buy |
|
|||||
|
2015
Q2 | $51.3M | Sell |
|
|||||
|
2015
Q1 | $80.8M | Sell |
|
|||||
|
2014
Q4 | $89.4M | Buy |
|
|||||
|
2014
Q3 | $35.8M | Buy |
|
|||||
|
2014
Q2 | $22.3M | Buy |
|
|||||
|
2014
Q1 | $16.3M | Sell |
|
|||||
|
2013
Q4 | $15M | Sell |
|
|||||
|
2013
Q3 | $25M | Buy |
|
|||||
|
2013
Q2 | $16.3M | Buy |
|